The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Agios
Stock and Other Ownership Interests - Agios
Consulting or Advisory Role - Advance Medical
Clinical pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced hematologic malignancies from a phase 1 study.
 
David Dai
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Courtney Denton Dinardo
Honoraria - Agios; Daiichi Sankyo; Novartis
Research Funding - Abbvie; AGIOS; Celgene; Daiichi Sankyo; Novartis
 
Eytan Stein
Consulting or Advisory Role - Agios; Bayer; Celgene; Novartis; Pfizer
 
Stéphane de Botton
Consulting or Advisory Role - Agios; Celgene; Novartis; Pfizer; Pierre Fabre; SERVIER
Research Funding - Agios
 
Eyal C. Attar
No Relationships to Disclose
 
Hua Liu
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Guowen Liu
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Ian Lemieux
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Samuel V. Agresta
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Hua Yang
Employment - Agios
Stock and Other Ownership Interests - Agios
 
Bin Fan
Employment - Agios
Stock and Other Ownership Interests - Agios